Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Rhea-AI Summary

Terns Pharmaceuticals (Nasdaq: TERN) announced that senior management will present at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.

A live webcast will be available on the company's investor relations site at http://ir.ternspharma.com, and a replay will be archived on the site for at least 30 days after the event.

News Market Reaction – TERN

+13.30%

51 alerts

+13.30% Session close to close

+8.0% Peak in 1 hr 45 min

$2.10B Market Cap

0.3x Rel. Volume

In the Nov 17 session, TERN gained 13.30%, reflecting a significant positive market reaction. Argus tracked a peak move of +8.0% during that session. Our momentum scanner triggered 51 alerts that day, indicating high trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be presenting at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:30 p.m. GMT.

A live webcast of the presentation will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for at least 30 days following the event.

About Terns Pharmaceuticals
Terns Pharmaceuticals is a clinical-stage oncology company reimagining known biology to deliver high impact medicines. Our lead program TERN-701 is a highly selective, allosteric BCR-ABL inhibitor with a potentially best-in-disease profile that could meaningfully improve upon the efficacy, safety and convenience of existing treatments for CML. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com

Media
Jenna Urban
CG Life
media@ternspharma.com

FAQ

When will Terns Pharmaceuticals (TERN) present at the Jefferies Global Healthcare Conference in London?

Terns will present on Monday, November 17, 2025 at 4:30 p.m. GMT.

How can investors watch the TERN presentation at the Jefferies conference?

A live webcast will be available on Terns' investor relations page at http://ir.ternspharma.com.

Will there be a replay of Terns Pharmaceuticals' (TERN) Jefferies presentation and for how long?

Yes. A replay will be archived on the company's website for at least 30 days after the event.

Which Terns management will present at the Jefferies Global Healthcare Conference (TERN)?

The announcement states that members of senior management will present; specific names were not provided.

Where can I find the webcast link for the Terns (TERN) presentation after the event?

The webcast and replay will be posted on Terns' investor relations website at http://ir.ternspharma.com.